Tonix Pharmaceuticals stock halted ahead of FDA approval news
Investing.com -- Evoke (LON:EVOK) on Wednesday reaffirmed its fiscal 2025 revenue growth forecast of 5% to 9% and projected EBITDA margins of at least 20%, which at the lower end of guidance equates to about £368 million, roughly 3% above market expectations of £356 million. Last-12-month EBITDA stood at £363 million.
Second-quarter revenue rose 5%, driven by a 6% increase in online sales, or 7% at constant currency, and a return to growth in retail.
iGaming posted double-digit gains in the quarter, while sports betting growth was lower due to comparisons with last year’s UEFA European Championship.
First-half group revenue increased 3% to £888 million, or 4% at constant currency. UK and Ireland online revenue fell 1%, but EBITDA in the segment rose 37% through marketing efficiencies, a focus on customer value and cost savings.
International revenue climbed 13% (15% at constant currency), with core markets including Italy, Spain, Romania and Denmark up 22% at constant currency.
UK and Ireland retail revenue declined 2% in the half but returned to growth in the second quarter following new gaming cabinet rollouts.
Leverage fell to about 5 times on a last-12-month basis, and cost savings remained on track.
For the third quarter to Aug. 10, revenue growth was in line with internal plans, supported by core market positions, new product launches and brand enhancements.
“We continue to see material longer-term equity upside as leverage reduces,” said analysts at Jefferies in a note.